Stanley L. Hazen

91.1k total citations · 29 hit papers
481 papers, 55.1k citations indexed

About

Stanley L. Hazen is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Stanley L. Hazen has authored 481 papers receiving a total of 55.1k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Molecular Biology, 178 papers in Physiology and 104 papers in Immunology. Recurrent topics in Stanley L. Hazen's work include Gut microbiota and health (85 papers), Diet and metabolism studies (80 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (76 papers). Stanley L. Hazen is often cited by papers focused on Gut microbiota and health (85 papers), Diet and metabolism studies (80 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (76 papers). Stanley L. Hazen collaborates with scholars based in United States, United Kingdom and Germany. Stanley L. Hazen's co-authors include W.H. Wilson Tang, Zeneng Wang, Yuping Wu, Xiaoming Fu, Bruce S. Levison, Jay W. Heinecke, Jonathan D. Smith, Aldons J. Lusis, Joseph A. DiDonato and Robert Koeth and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

Stanley L. Hazen

466 papers receiving 54.2k citations

Hit Papers

Gut flora metabolism of phosphatidylcholine ... 1997 2026 2006 2016 2011 2013 2016 2017 2015 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
    2011 4.1k citations Zeneng Wang, Robert Koeth et al. profile →
  2. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
    2013 2.4k citations W.H. Wilson Tang, Zeneng Wang et al. profile →
  3. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
    2016 1.4k citations Jennifer A. Buffa, Zeneng Wang et al. profile →
  4. Gut Microbiota in Cardiovascular Health and Disease
    2017 1.2k citations W.H. Wilson Tang, Stanley L. Hazen et al. profile →
  5. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis
    2015 996 citations Zeneng Wang, Jennifer A. Buffa et al. profile →
  6. Gut Microbiota-Dependent Trimethylamine N -Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
    2014 955 citations W.H. Wilson Tang, Zeneng Wang et al. profile →
  7. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
    2000 816 citations Maria Febbraio, Eugene A. Podrez et al. Journal of Clinical Investigation profile →
  8. Trimethylamine-N-Oxide, a Metabolite Associated with Atherosclerosis, Exhibits Complex Genetic and Dietary Regulation
    2013 812 citations Zeneng Wang, Diana M. Shih et al. profile →
  9. Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB
    2016 704 citations Zeneng Wang, Stanley L. Hazen et al. Journal of the American Heart Association profile →
  10. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
    1997 697 citations Stanley L. Hazen, Jay W. Heinecke Journal of Clinical Investigation profile →
  11. Gut Microbiota and Cardiovascular Disease
    2020 651 citations Marco Witkowski, Stanley L. Hazen et al. profile →
  12. Myeloperoxidase and Cardiovascular Disease
    2005 607 citations Stephen J. Nicholls, Stanley L. Hazen profile →
  13. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
    2004 577 citations Lemin Zheng, Mingjiang Sun et al. Journal of Clinical Investigation profile →
  14. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease
    2004 563 citations Lemin Zheng, Marie‐Luise Brennan et al. Journal of Clinical Investigation profile →
  15. Dietary metabolism, the gut microbiome, and heart failure
    2018 545 citations W.H. Wilson Tang, Daniel Y. Li et al. profile →
  16. Protein carbamylation links inflammation, smoking, uremia and atherogenesis
    2007 544 citations Zeneng Wang, Stephen J. Nicholls et al. profile →
  17. Statins, High-Density Lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis
    2007 543 citations Stephen J. Nicholls, Stanley L. Hazen et al. profile →
  18. Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure
    2014 536 citations W.H. Wilson Tang, Zeneng Wang et al. profile →
  19. Myeloperoxidase-generated oxidants and atherosclerosis
    2000 520 citations Eugene A. Podrez, Stanley L. Hazen et al. profile →
  20. The contributory role of gut microbiota in cardiovascular disease
    2014 501 citations W.H. Wilson Tang, Stanley L. Hazen Journal of Clinical Investigation profile →
  21. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors
    2020 489 citations Ina Nemet, Prasenjit Prasad Saha et al. profile →
  22. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide
    2014 458 citations W.H. Wilson Tang, Jennifer A. Buffa et al. European Heart Journal profile →
  23. γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
    2014 424 citations Robert Koeth, Bruce S. Levison et al. profile →
  24. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women
    2018 348 citations Zeneng Wang, Bruce S. Levison et al. European Heart Journal profile →
  25. Intestinal Microbiota in Cardiovascular Health and Disease
    2019 341 citations W.H. Wilson Tang, Fredrik Bäckhed et al. profile →
  26. Microbial modulation of cardiovascular disease
    2018 321 citations Stanley L. Hazen et al. profile →
  27. The artificial sweetener erythritol and cardiovascular event risk
    2023 115 citations Marco Witkowski, Ina Nemet et al. profile →
  28. Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
    2024 63 citations W.H. Wilson Tang, Xinmin S. Li et al. profile →
  29. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
    2024 59 citations Zeneng Wang, Xinmin S. Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stanley L. Hazen United States 119 26.2k 19.1k 10.1k 7.4k 6.4k 481 55.1k
Aldons J. Lusis United States 116 30.8k 1.2× 12.1k 0.6× 10.5k 1.0× 11.3k 1.5× 6.3k 1.0× 617 63.9k
Amirhossein Sahebkar Iran 127 22.9k 0.9× 6.9k 0.4× 8.4k 0.8× 9.2k 1.2× 4.2k 0.6× 1.9k 69.4k
Timothy R. Billiar United States 122 19.5k 0.7× 12.6k 0.7× 14.0k 1.4× 9.4k 1.3× 3.2k 0.5× 781 57.3k
Takashi Kadowaki Japan 119 25.1k 1.0× 16.3k 0.9× 5.3k 0.5× 10.4k 1.4× 7.6k 1.2× 869 62.0k
Gökhan S. Hotamışlıgil United States 105 26.3k 1.0× 24.3k 1.3× 9.6k 0.9× 9.6k 1.3× 6.5k 1.0× 178 71.9k
Csaba Szabó United States 117 16.1k 0.6× 11.5k 0.6× 6.9k 0.7× 3.8k 0.5× 4.8k 0.8× 682 51.1k
David G. Harrison United States 134 14.1k 0.5× 23.3k 1.2× 10.0k 1.0× 7.3k 1.0× 20.4k 3.2× 400 60.5k
Ann Marie Schmidt United States 113 13.3k 0.5× 9.7k 0.5× 7.4k 0.7× 3.0k 0.4× 3.6k 0.6× 395 49.7k
Johan Auwerx Switzerland 157 51.3k 2.0× 29.9k 1.6× 5.5k 0.5× 12.8k 1.7× 3.9k 0.6× 638 96.6k
Friedrich C. Luft Germany 112 12.8k 0.5× 8.8k 0.5× 4.7k 0.5× 6.8k 0.9× 16.9k 2.6× 1.1k 50.6k

Countries citing papers authored by Stanley L. Hazen

Since Specialization
Citations

This map shows the geographic impact of Stanley L. Hazen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley L. Hazen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley L. Hazen more than expected).

Fields of papers citing papers by Stanley L. Hazen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stanley L. Hazen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley L. Hazen. The network helps show where Stanley L. Hazen may publish in the future.

Co-authorship network of co-authors of Stanley L. Hazen

This figure shows the co-authorship network connecting the top 25 collaborators of Stanley L. Hazen. A scholar is included among the top collaborators of Stanley L. Hazen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stanley L. Hazen. Stanley L. Hazen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yu-Jen, Daniel S. Gaul, Era Gorica, et al.. (2025). NAD+ boosting increases atherosclerotic plaques and inflammation in Apoe knockout mice. Atherosclerosis. 404. 119188–119188. 1 indexed citations
2.
Tang, W.H. Wilson, Ina Nemet, Xinmin S. Li, et al.. (2023). Prognostic Value of Gut Microbe-Generated Metabolite Phenylacetylglutamine in Patients with Heart Failure. European Journal of Heart Failure. 26(2). 233–241. 18 indexed citations
3.
Mohan, Maradumane L., Yuji Nagatomo, Prasenjit Prasad Saha, et al.. (2021). The IgG3 subclass of β1-adrenergic receptor autoantibodies is an endogenous biaser of β1AR signaling. Molecular Biology of the Cell. 32(7). 622–633. 4 indexed citations
4.
Li, Daniel Y., Zeneng Wang, Xun Jia, et al.. (2021). Loop Diuretics Inhibit Renal Excretion of Trimethylamine N-Oxide. JACC Basic to Translational Science. 6(2). 103–115. 13 indexed citations
5.
Kruse, Megan, Mona Patel, Jeffrey M. McManus, et al.. (2021). Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer. JCI Insight. 6(20). 15 indexed citations
6.
Reichard, Chad A., Zeneng Wang, Xun Jia, et al.. (2021). Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort. Cancer Epidemiology Biomarkers & Prevention. 31(1). 192–199. 35 indexed citations
7.
Witkowski, Marco, Mario Witkowski, Julian Friebel, et al.. (2021). Vascular endothelial tissue factor contributes to trimethylamine N-oxide-enhanced arterial thrombosis. Cardiovascular Research. 118(10). 2367–2384. 72 indexed citations
8.
Smits, Loek P., Ruud S. Kootte, Evgeni Levin, et al.. (2018). Effect of Vegan Fecal Microbiota Transplantation on Carnitine‐ and Choline‐Derived Trimethylamine‐N‐Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome. Journal of the American Heart Association. 7(7). 196 indexed citations
9.
Guertin, Kristin A., Xinmin S. Li, Barry I. Graubard, et al.. (2017). Serum Trimethylamine N-oxide, Carnitine, Choline, and Betaine in Relation to Colorectal Cancer Risk in the Alpha Tocopherol, Beta Carotene Cancer Prevention Study. Cancer Epidemiology Biomarkers & Prevention. 26(6). 945–952. 70 indexed citations
10.
Organ, Chelsea L., et al.. (2016). Abstract 19293: Removal of Dietary Trimethylamine N-Oxide (TMAO) Attenuates Cardiac Dysfunction in Pressure Overload Induced Heart Failure. Circulation. 1 indexed citations
11.
Tang, W.H. Wilson, Jennifer A. Buffa, Xiaoming Fu, et al.. (2014). Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. European Heart Journal. 35(14). 904–910. 458 indexed citations breakdown →
12.
Tang, W.H. Wilson, Zeneng Wang, Kevin Shrestha, et al.. (2014). Intestinal Microbiota-Dependent Phosphatidylcholine Metabolites, Diastolic Dysfunction, and Adverse Clinical Outcomes in Chronic Systolic Heart Failure. Journal of Cardiac Failure. 21(2). 91–96. 275 indexed citations
13.
Holguín, Fernando, Suzy Comhair, Stanley L. Hazen, et al.. (2012). An Association between l -Arginine/Asymmetric Dimethyl Arginine Balance, Obesity, and the Age of Asthma Onset Phenotype. American Journal of Respiratory and Critical Care Medicine. 187(2). 153–159. 127 indexed citations
14.
Wu, Zhiping, Valentin Gogonea, Xavier Lee, et al.. (2011). The Low Resolution Structure of ApoA1 in Spherical High Density Lipoprotein Revealed by Small Angle Neutron Scattering. Journal of Biological Chemistry. 286(14). 12495–12508. 44 indexed citations
15.
Nicholls, Stephen J., W.H. Wilson Tang, Danielle M. Brennan, et al.. (2010). Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. Journal of Lipid Research. 51(10). 3055–3061. 69 indexed citations
16.
Comhair, Suzy, Kristin Ricci, Mercedes E. Arroliga, et al.. (2005). Correlation of Systemic Superoxide Dismutase Deficiency to Airflow Obstruction in Asthma. American Journal of Respiratory and Critical Care Medicine. 172(3). 306–313. 130 indexed citations
17.
Zheng, Lemin, Marie‐Luise Brennan, Mingjiang Sun, et al.. (2004). Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. Journal of Clinical Investigation. 114(4). 529–541. 563 indexed citations breakdown →
18.
Brennan, Marie‐Luise, Melissa M. Anderson, Diana M. Shih, et al.. (2001). Increased atherosclerosis in myeloperoxidase-deficient mice. Journal of Clinical Investigation. 107(4). 419–430. 261 indexed citations
19.
Febbraio, Maria, Eugene A. Podrez, Jonathan D. Smith, et al.. (2000). Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. Journal of Clinical Investigation. 105(8). 1049–1056. 816 indexed citations breakdown →
20.
Hazen, Stanley L., Fong‐Fu Hsu, Joseph P. Gaut, Jan R. Crowley, & Jay W. Heinecke. (1999). Modification of proteins and lipids by myeloperoxidase. Methods in enzymology on CD-ROM/Methods in enzymology. 300. 88–105. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aldons J. Lusis Breakdown of academic impact, for papers by Amirhossein Sahebkar Breakdown of academic impact, for papers by Timothy R. Billiar Breakdown of academic impact, for papers by Takashi Kadowaki Breakdown of academic impact, for papers by Gökhan S. Hotamışlıgil Breakdown of academic impact, for papers by Csaba Szabó Breakdown of academic impact, for papers by David G. Harrison Breakdown of academic impact, for papers by Ann Marie Schmidt Breakdown of academic impact, for papers by Johan Auwerx Breakdown of academic impact, for papers by Friedrich C. Luft
Rankless by CCL
2026